SCHEMBL4299636

SCHEMBL4299636

CCCCCCCCCCCCCCCCCC(CCCCCCCCCCCCCC)C1(O)CCO1

nearest known ligand 0.38

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3259895 1.00 LMNA (0.38) LMNA
SCHEMBL9247244 1.00 LMNA (0.38) LMNA
SCHEMBL1628089 0.76 LMNA (0.32) LMNA
SCHEMBL5137369 0.74 LMNA (0.44) LMNA
SCHEMBL11151405 0.74 DNM1 (0.34) LMNA
Hydrochloric Acid SCHEMBL10588512 0.73 OPRM1 (0.32) LMNA
SCHEMBL3804023 0.73 LMNA (0.42) LMNA
SCHEMBL6556644 0.73 SPHK1 (0.36) LMNA
SCHEMBL3419500 0.72 GPR84 (0.37) LMNA
SCHEMBL21030192 0.71 LMNA (0.39) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2011508-B1 USE OF TRAP PROTEIN PER SE AS ACTIVE INGREDIENT FOR MANUFACTURING A MEDICAMENT FOR THE TREATMENT OF STAPHYLOCOCCUS AUREUS INFECTION HAINAN GT UNIPUL PHARMACEUTICAL CO LTD (CN) 2012-08-22 EP disclosed
US-20090305975-A1 Use of Trap Protein Per se as an Active Ingredient for the Manufacture of a Medicament for the Treatment of Staphylococcus Aureus Infection HAINAN GT-UNIPUL PHARMACEUTICAL CO. LTD. (CN) 2009-12-10 US disclosed
EP-2011508-A1 USE OF TRAP PROTEIN AS ACTIVE INGREDIENT FOR MANUFACTURING A MEDICAMENT FOR THE TREATMENT OF STAPHYLOCOCCUS AUREUS INFECTION Institute of Basic Medical Sciences Academy of Military Medical Sciences (CN) 2009-01-07 EP disclosed